{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:58:46Z","timestamp":1794031126988,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tcm.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:20:55Z","timestamp":1692955255000},"page":"371-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Practical solutions for implementation of blood cholesterol guidelines in clinical practice"],"prefix":"10.1016","volume":"34","author":[{"given":"Gregory","family":"Piazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihar R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Exter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Kalich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2023.08.001_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100010","article-title":"Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States","volume":"1","author":"Klimchak","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ahj.2019.10.014","article-title":"Getting to an improved understanding of low-density lipoprotein-cholesterol and dyslipidemia management (GOULD): methods and baseline data of a registry of high cardiovascular risk patients in the United States","volume":"219","author":"Cannon","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2023.08.001_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0004","series-title":"Poster presented at the national lipid association meeting","article-title":"GOULD EDU: primary results of a cluster-randomized trial of an educational intervention to improve guideline adherence and intensification of lipid-lowering therapy","author":"Kosiborod","year":"2022"},{"key":"10.1016\/j.tcm.2023.08.001_bib0005","first-page":"1","article-title":"Lipid management across Europe in the real-world setting: a rapid evidence review","author":"Barrios","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.tcm.2023.08.001_bib0006","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.jacc.2017.03.585","article-title":"Trends in the use of high-intensity statin therapy after myocardial infarction, 2011-2014","volume":"69","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005627","article-title":"Implications of American College of Cardiology\/American Heart Association (ACC\/AHA) cholesterol guidelines on statin underutilization for prevention of cardiovascular disease in diabetes mellitus among several US networks of community health centers","volume":"6","author":"Akhabue","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"25 Suppl 2","key":"10.1016\/j.tcm.2023.08.001_bib0008","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.08.001_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ahj.2012.05.021","article-title":"Disability, race\/ethnicity, and medication adherence among Medicare myocardial infarction survivors","volume":"164","author":"Zhang","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2023.08.001_bib0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the Patient and Provider Assessment of Lipid Management Registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0011","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2023.08.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020893","article-title":"What do US physicians and patients think about lipid-lowering therapy and goals of treatment? Results from the GOULD Registry","volume":"10","author":"Arnold","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2023.08.001_bib0013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cjco.2020.07.002","article-title":"Barriers and facilitators to using statins: a qualitative study with patients and family physicians","volume":"2","author":"Butalia","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.tcm.2023.08.001_bib0014","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/JHQ.0000000000000111","article-title":"Breaking the barriers in resident education: a quality improvement initiative","volume":"40","author":"Cabarga","year":"2018","journal-title":"J Healthc Qual"},{"key":"10.1016\/j.tcm.2023.08.001_bib0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacl.2017.04.120","article-title":"Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: results of a healthcare provider survey conducted by the National Lipid Association","volume":"11","author":"Cohen","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0016","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.2196\/humanfactors.9030","article-title":"Designing for clinical change: creating an intervention to implement new statin guidelines in a primary care clinic","volume":"5","author":"DeJonckheere","year":"2018","journal-title":"JMIR Hum Factors"},{"key":"10.1016\/j.tcm.2023.08.001_bib0017","article-title":"Examination of physicians' adherence to the 2013 ACC\/AHA statin\/cholesterol guidelines using a framework of awareness to adherence: a cross-sectional study","volume":"9","author":"Fleming","year":"2020","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2023.08.001_bib0018","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/00325481.2020.1758489","article-title":"Evaluation of internal medicine physicians' attitudes toward the treatment of dyslipidemia","volume":"132","author":"Kara","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.tcm.2023.08.001_bib0019","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjcard.2018.12.031","article-title":"Association of clinician knowledge and statin beliefs with statin therapy use and lipid levels (a survey of US practice in the PALM Registry)","volume":"123","author":"Lowenstern","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0020","first-page":"1517","article-title":"A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model","volume":"26","author":"McCormick","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.tcm.2023.08.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005404","article-title":"Effect of access to prescribed PCSK9 inhibitors on cardiovascular outcomes","volume":"12","author":"Myers","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.tcm.2023.08.001_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pcad.2022.11.009","article-title":"Guidelines for the management of hyperlipidemia: how can clinicians effectively implement them?","volume":"75","author":"Dembowski","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2023.08.001_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.713007","article-title":"Efficacy and safety of lipid-lowering drugs of different intensity on clinical outcomes: a systematic review and network meta-analysis","volume":"12","author":"Ma","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0024","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.08.001_bib0025","doi-asserted-by":"crossref","first-page":"a2286","DOI":"10.1136\/bmj.a2286","article-title":"Statin induced myopathy","volume":"337","author":"Sathasivam","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.08.001_bib0026","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.08.001_bib0027","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0028","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/bmj.318.7193.1269","article-title":"Evaluating educational interventions","volume":"318","author":"Wilkes","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.08.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006808","article-title":"The effectiveness of toolkits as knowledge translation strategies for integrating evidence into clinical care: a systematic review","volume":"5","author":"Yamada","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.tcm.2023.08.001_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s43058-020-00081-x","article-title":"Development and use of a toolkit to facilitate implementation of an evidence-based intervention: a descriptive case study","volume":"1","author":"Thoele","year":"2020","journal-title":"Implement Sci Commun"},{"key":"10.1016\/j.tcm.2023.08.001_bib0031","unstructured":"American College of Cardiology. Clinical toolkits. 2022. https:\/\/www.acc.org\/tools-and-practice-support\/clinical-toolkits. Accessed January 10, 2023."},{"key":"10.1016\/j.tcm.2023.08.001_bib0032","unstructured":"American Heart Association. The Lp(a): A toolkit for health care professionals. 2021. http:\/\/aha-clinical-review.ascendeventmedia.com\/books\/lpa-a-toolkit-for-health-care-professionals. Accessed January 10, 2023."},{"key":"10.1016\/j.tcm.2023.08.001_bib0033","doi-asserted-by":"crossref","DOI":"10.4137\/JMECD.S20377","article-title":"Case-based learning and its application in medical and health-care fields: a review of worldwide literature","volume":"3","author":"McLean","year":"2016","journal-title":"J Med Educ Curric Dev"},{"key":"10.1016\/j.tcm.2023.08.001_bib0034","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCULATIONAHA.109.884031","article-title":"Computerized decision support for the cardiovascular clinician","volume":"120","author":"Piazza","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.08.001_bib0035","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/eurheartj\/ehz385","article-title":"Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT)","volume":"41","author":"Piazza","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.08.001_bib0036","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.107.697201","article-title":"Electronic alerts versus on-demand decision support to improve dyslipidemia treatment","volume":"117","author":"van Wyk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.08.001_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1525-1497.2005.00268.x","article-title":"Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease","volume":"21","author":"Lester","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.tcm.2023.08.001_bib0038","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4338\/ACI-2016-01-RA-0003","article-title":"Patient portals: who uses them? What features do they use? And do they reduce hospital readmissions?","volume":"7","author":"Griffin","year":"2016","journal-title":"Appl Clin Inform"},{"key":"10.1016\/j.tcm.2023.08.001_bib0039","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacl.2013.10.004","article-title":"Effect of health information technology interventions on lipid management in clinical practice: a systematic review of randomized controlled trials","volume":"7","author":"Aspry","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0040","series-title":"Presented at the 95th annual scientific sessions of the American heart association featured science presentation for digital innovations to improve CVD prevention","article-title":"A PROMPT-lipid","author":"Shah","year":"2022"},{"key":"10.1016\/j.tcm.2023.08.001_bib0041","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/jama.2014.15600","article-title":"Elimination of lipid levels from quality measures: implications and alternatives","volume":"312","author":"Stine","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2023.08.001_bib0042","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.167.14.1493","article-title":"mInfluence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)","volume":"167","author":"Fonarow","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tcm.2023.08.001_bib0043","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/HCQ.0000000000000014","article-title":"2015 ACC\/AHA focused update of secondary prevention lipid performance measures","volume":"9","author":"Drozda","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.tcm.2023.08.001_bib0044","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019254","article-title":"Factors associated with PCSK9 inhibitor initiation among US veterans","volume":"10","author":"Derington","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2023.08.001_bib0045","unstructured":"National Black Leadership Commission on Health. Advocacy and Policy. 2022. https:\/\/nblch.org\/advocacy-policy. Accessed January 10, 2023."},{"key":"10.1016\/j.tcm.2023.08.001_bib0046","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2023.08.001_bib0047","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","article-title":"Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality","volume":"68","author":"Besseling","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0048","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2023.08.001_bib0049","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/clc.23706","article-title":"Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease","volume":"44","author":"Fonarow","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0828-282X(06)70928-X","article-title":"The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention","volume":"22","author":"Ma","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2023.08.001_bib0051","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.atherosclerosissup.2021.01.010","article-title":"Implementation of clinical practices and pathways optimizing ACS patients lipid management: focus on eight European initiatives","volume":"42","author":"Alings","year":"2020","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.tcm.2023.08.001_bib0052","first-page":"141","article-title":"Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications","volume":"20","author":"Clark","year":"2014","journal-title":"J Manag Care Pharm"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T23:03:41Z","timestamp":1722899021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173823000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1050173823000749"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2023.08.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical solutions for implementation of blood cholesterol guidelines in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}